Adjuvant aumolertinib in resected EGFR-mutated non-small cell lung cancer: A multiple-center real-world experience

被引:0
|
作者
Zhang, Q. [1 ]
Ke, L. [1 ]
Huang, S. [2 ]
Yang, Y. [1 ]
He, T. [1 ]
Sun, H. [3 ]
Wu, Z. [1 ]
Zhang, X. [4 ]
Zhang, H. [5 ]
Lv, W. [1 ]
Hu, J. [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Thorac Surg, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Thorac Surg, Hangzhou, Peoples R China
[3] Zhejiang Univ, Taizhou Hosp, Dept Thorac Surg, Taizhou, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Wenzhou, Peoples R China
[5] Sci Grp Cent Med, Dept Med Oncol, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
98P
引用
收藏
页码:S98 / S98
页数:1
相关论文
共 50 条
  • [41] Assessing tolerability and toxicity of adjuvant Osimertinib following tumour resection of early-stage EGFR-mutated non-small cell lung cancer through real-world data
    Afxentiou, Thalia
    Wontumi, Sabihya
    Achim, Tabitha
    Ehsan, Mujtaba
    Henderson, Karen
    Ahmed, Ridwan
    Polychronis, Andreas
    Antoniou, Georgios
    Xhafa-Hamiti, Ernese
    Denton, Arshi
    Mawdsley, Suzannah
    Dickson, Jeanette
    Basu, Suprotim
    Dubash, Suraiya
    LUNG CANCER, 2024, 190
  • [42] Adjuvant treatment for EGFR-mutated non-small cell lung cancer: do we have a major breakthrough?
    Roviello, Giandomenico
    Imperatori, Marco
    Aieta, Michele
    Sollitto, Francesco
    Landriscina, Matteo
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S2114 - S2118
  • [43] Real-world outcomes of anti-EGFR therapy in advanced non-small cell lung cancer EGFR mutated in Peru
    Galvez-Nino, Marco
    Ruiz, Rossana
    Roque, Katia
    Coanqui, Ofelia
    Valdivieso, Natalia
    Olivera, Mivael
    Ganti, Apar Kishor
    Mas, Luis
    THORACIC CANCER, 2023, 14 (01) : 61 - 67
  • [44] Cost-effectiveness of osimertinib versus placebo in resected EGFR-mutated non-small cell lung cancer in China
    Zhou, Xiwen
    Du, Jianting
    Xu, Guobing
    Chen, Chun
    Zheng, Bin
    Chen, Jiahe
    CANCER MEDICINE, 2022, 11 (23): : 4449 - 4456
  • [45] Real-World T790M Mutation Frequency and Impact of Rebiopsy in Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer
    Pereira, Isabel
    Gaspar, Catia
    Pina, Marta
    Azevedo, Isabel
    Rodrigues, Ana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [46] Afatinib After Progression on Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer
    Aredo, Jacqueline, V
    Wakelee, Heather A.
    Neal, Joel W.
    Padda, Sukhmani K.
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 30
  • [47] Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
    Felip, Enriqueta
    Metro, Giulio
    Soo, Ross A.
    Wolf, Juergen
    Solomon, Benjamin J.
    Tan, Daniel S. W.
    Ardizzoni, Andrea
    Lee, Dae Ho
    Sequist, Lecia V.
    Barlesi, Fabrice
    Ponce-Aix, Santiago
    Abreu, Delvys Rodriguez
    Campelo, Maria Rosario Garcia
    Sprauten, Mette
    Djentuh, Leslie O'Sullivan
    Smith, Nathalie
    Jary, Aline
    Belli, Riccardo
    Glaser, Sabine
    Zou, Mike
    Cui, Xiaoming
    Giovannini, Monica
    Yang, James Chih-Hsin
    EUROPEAN JOURNAL OF CANCER, 2024, 208
  • [48] Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer
    Bhandari, Shruti
    Dunlap, Neal
    Kloecker, Goetz
    JOURNAL OF THORACIC DISEASE, 2021, 13 (05) : 3230 - 3234
  • [49] Deciphering the Characterization of Tumor Microenvironment in EGFR-Mutated Non-Small Cell Lung Cancer
    Qiao, M.
    Jiang, T.
    Ren, S.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S182 - S183
  • [50] Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
    Steendam, Christi M. J.
    Veerman, G. D. Marijn
    Pruis, Melinda A.
    Atmodimedjo, Peggy
    Paats, Marthe S.
    van der Leest, Cor
    von der Thusen, Jan H.
    Yick, David C. Y.
    Oomen-de Hoop, Esther
    Koolen, Stijn L. W.
    Dinjens, Winand N. M.
    van Schaik, Ron H. N.
    Mathijssen, Ron H. J.
    Aerts, Joachim G. J. V.
    Dubbink, Hendrikus Jan
    Dingemans, Anne-Marie C.
    CANCERS, 2020, 12 (11) : 1 - 17